SummitTX Capital’s Stryker SYK Stock Holding History

SummitTX Capital’s Portfolio SYK Stock Details SYK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-14,534	Closed	-$5.41M	–	999
2025 Q1	$5.41M	Buy	+14,534	New	+$5.53M	0.23%	107

Other funds holding SYK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Greenleaf Trust Kalamazoo, Michigan $10.4B AUM 0.97% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

SummitTX Capital's SYK Position: Q2 2025 in Review

SummitTX Capital sold out of Stryker (SYK) in Q2 2025, closing a stake of 14,534 shares — an estimated $5.41M sold.

SummitTX Capital first reported a position in SYK in Q1 2025 and held it in 1 quarter. The position peaked at $5.41M in Q1 2025. 2,254 funds tracked by Wall St. Rank hold SYK as of Q2 2025.

SummitTX Capital reported no remaining Stryker position as of Q2 2025 after selling out during the quarter.
SummitTX Capital sold 14,534 Stryker shares in Q2 2025, an estimated $5.41M.
SummitTX Capital first reported a position in Stryker in Q1 2025 and held it in 1 quarter.
SummitTX Capital's Stryker position peaked at $5.41M in Q1 2025.
2,254 funds tracked by Wall St. Rank held Stryker as of Q2 2025.

Based on SummitTX Capital's 13F filing for Q2 2025, filed 14 Aug 2025.